MarketCap
Facebook
X
Telegram
Vascular Biogenics Ltd. EV/EBITDA Ratio | VBLT
Annual EV/EBITDA Ratio Vascular Biogenics Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.477 | -0.448 | -4.22 | -3.44 | -2.47 | 0.456 | -18.2 | 890 | 445 | 144 M | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 144 M | -18.2 | 14.4 M |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerus Corporation
CERS
|
-87.2 | $ 1.95 | -6.04 % | $ 372 M |  USA |
 |
Beam Therapeutics
BEAM
|
-8.71 | $ 25.16 | -6.88 % | $ 2.49 B | USA |
 |
Pulmatrix
PULM
|
-3.93 K | $ 1.39 | 2.58 % | $ 5.08 B | USA |
 |
Fortress Biotech
FBIO
|
-1.74 | $ 1.9 | -4.52 % | $ 53 M | USA |
 |
Inhibrx
INBX
|
-7.95 | $ 90.63 | -1.21 % | $ 4.27 B | USA |
 |
Entera Bio Ltd.
ENTX
|
-7.43 | $ 3.24 | -0.31 % | $ 150 M |  Israel |
 |
Flexion Therapeutics, Inc.
FLXN
|
-7.1 | - | - | $ 459 M | USA |
 |
Legend Biotech Corporation
LEGN
|
-49.4 | $ 20.25 | -16.63 % | $ 7.46 B | USA |
 |
CytomX Therapeutics
CTMX
|
-45.9 | $ 2.0 | 0.76 % | $ 276 M | USA |
 |
Krystal Biotech
KRYS
|
48.4 | $ 306.47 | 1.13 % | $ 8.87 B | USA |
 |
Kura Oncology
KURA
|
-3.8 | $ 7.56 | -0.13 % | $ 663 M | USA |
 |
Inhibikase Therapeutics
IKT
|
0.198 | $ 1.58 | -6.25 % | $ 155 M | USA |
 |
Heron Therapeutics
HRTX
|
-1.84 K | $ 0.38 | 1.38 % | $ 63.3 M | USA |
 |
Inovio Pharmaceuticals
INO
|
-1.22 | $ 1.47 | -2.98 % | $ 68.9 M | USA |
 |
Corvus Pharmaceuticals
CRVS
|
-7.55 | $ 11.36 | 0.09 % | $ 897 M | USA |
 |
Aytu BioScience
AYTU
|
-0.265 | $ 1.83 | 2.23 % | $ 22.5 M | USA |
 |
Heat Biologics, Inc.
HTBX
|
-0.885 | - | -5.76 % | $ 99.8 M | USA |
 |
Innoviva
INVA
|
5.64 | $ 19.08 | 0.39 % | $ 1.29 B | USA |
 |
BioCardia
BCDA
|
-0.98 | $ 0.95 | 2.66 % | $ 6.33 M | USA |
 |
Kindred Biosciences, Inc.
KIN
|
-18.5 | - | 0.11 % | $ 419 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 2.3 | -5.35 % | $ 14.7 B |  Australia |
 |
Shineco, Inc.
TYHT
|
3.76 | - | -3.90 % | $ 97.2 M |  China |
 |
Millendo Therapeutics, Inc.
MLND
|
1.01 | - | -5.36 % | $ 20.2 M | USA |
 |
Certara
CERT
|
14.4 | $ 12.21 | -0.08 % | $ 1.96 B | USA |
 |
Dyadic International
DYAI
|
-4.95 | $ 0.39 | 1.16 % | $ 14.1 M | USA |
 |
Intec Pharma Ltd
NTEC
|
-0.115 | - | -12.45 % | $ 17.7 M | Israel |
 |
Anika Therapeutics
ANIK
|
-27.5 | $ 13.42 | -7.89 % | $ 192 M | USA |
 |
Aprea Therapeutics
APRE
|
0.729 | $ 0.45 | -9.44 % | $ 2.94 M | USA |
 |
Galectin Therapeutics
GALT
|
-15.3 | $ 3.4 | -1.73 % | $ 217 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
83.2 | $ 73.22 | -2.41 % | $ 7.6 B | USA |
 |
Progenity, Inc.
PROG
|
-2.15 | - | -3.47 % | $ 164 M | USA |
 |
Genprex
GNPX
|
0.257 | $ 2.1 | 1.94 % | $ 1.96 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
-2.13 | - | 1.52 % | $ 136 M | USA |
 |
Innate Pharma S.A.
IPHA
|
-1.82 | $ 1.54 | 1.98 % | $ 138 M |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
0.944 | - | -1.19 % | $ 28.7 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
24.3 | $ 57.1 | -0.14 % | $ 11 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
-0.161 | $ 1.19 | -4.03 % | $ 6.51 M | USA |
 |
Enanta Pharmaceuticals
ENTA
|
-2.28 | $ 11.24 | -2.01 % | $ 240 K | USA |
 |
SIGA Technologies
SIGA
|
11.1 | $ 3.14 | -3.83 % | $ 225 M | USA |
 |
Milestone Pharmaceuticals
MIST
|
-2.31 | $ 0.68 | -7.49 % | $ 72.2 M |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
42 | $ 94.9 | -3.91 % | $ 7.04 B | USA |
 |
Lipocine
LPCN
|
-1.47 | $ 1.59 | -7.85 % | $ 8.66 M | USA |
 |
PTC Therapeutics
PTCT
|
8.48 | $ 64.12 | -1.4 % | $ 5.1 B | USA |
 |
Seres Therapeutics
MCRB
|
-1.23 | $ 1.55 | -8.75 % | $ 13.7 M | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
-34.7 | $ 432.48 | -0.07 % | $ 9.7 B | USA |
 |
CEL-SCI Corporation
CVM
|
-0.928 | $ 1.41 | 4.07 % | $ 11.3 M | USA |
 |
Inventiva S.A.
IVA
|
-3.2 | $ 3.95 | 2.73 % | $ 236 M | France |
 |
MeiraGTx Holdings plc
MGTX
|
-8.94 | $ 9.62 | 1.37 % | $ 774 M | USA |
 |
Processa Pharmaceuticals
PCSA
|
-0.0598 | $ 1.86 | -4.62 % | $ 2.44 M | USA |
 |
Eton Pharmaceuticals
ETON
|
187 | $ 67.5 | 4.9 % | $ 1.82 B | USA |